Abstract
The structure-based design, chemical synthesis, and biological evaluation of various human rhinovirus (HRV) 3C protease (3CP) inhibitors which incorporate P1 lactam moieties in lieu of an L-glutamine residue are described. These compounds are comprised of a tripeptidyl or peptidomimetic binding determinant and an ethyl propenoate Michael acceptor moiety which forms an irreversible covalent adduct with the active site cysteine residue of the 3C enzyme. The P1-lactam-containing inhibitors display significantly increased 3CP inhibition activity along with improved antirhinoviral properties relative to corresponding L-glutamine-derived molecules. In addition, several lactam-containing compounds exhibit excellent selectivity for HRV 3CP over several other serine and cysteine proteases and are not appreciably degraded by a variety of biological agents. One of the most potent inhibitors (AG7088, mean antirhinoviral EC90 approximately 0.10 microM, n = 46 serotypes) is shown to warrant additional preclinical development to explore its potential for use as an antirhinoviral agent.
MeSH terms
-
3C Viral Proteases
-
Antiviral Agents / chemical synthesis*
-
Antiviral Agents / chemistry
-
Antiviral Agents / pharmacology
-
Cell Line
-
Crystallography, X-Ray
-
Cysteine Endopeptidases / metabolism*
-
Cysteine Proteinase Inhibitors / chemical synthesis*
-
Cysteine Proteinase Inhibitors / chemistry
-
Cysteine Proteinase Inhibitors / pharmacology
-
Drug Design
-
Drug Evaluation, Preclinical
-
Glutamine / chemistry*
-
Humans
-
Isoxazoles / chemical synthesis*
-
Isoxazoles / chemistry
-
Isoxazoles / pharmacology
-
Lactams / chemical synthesis*
-
Lactams / chemistry
-
Lactams / pharmacology
-
Models, Molecular
-
Molecular Mimicry
-
Oligopeptides / chemical synthesis*
-
Oligopeptides / chemistry
-
Oligopeptides / pharmacology
-
Phenylalanine / analogs & derivatives
-
Pyrrolidinones / chemical synthesis*
-
Pyrrolidinones / chemistry
-
Pyrrolidinones / pharmacology
-
Rhinovirus / drug effects
-
Rhinovirus / enzymology*
-
Structure-Activity Relationship
-
Valine / analogs & derivatives
-
Viral Proteins*
Substances
-
Antiviral Agents
-
Cysteine Proteinase Inhibitors
-
Isoxazoles
-
Lactams
-
Oligopeptides
-
Pyrrolidinones
-
Viral Proteins
-
Glutamine
-
Phenylalanine
-
Cysteine Endopeptidases
-
3C Viral Proteases
-
Valine
-
rupintrivir